Screener
AbCellera Biologics Inc. ABCL Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:38 PM EST
- Fiscal year
- FY2025
- Accession
- 0001703057-26-000012
FAQ
- What is AbCellera Biologics Inc.'s operating lease liabilities (total)?
- AbCellera Biologics Inc. (ABCL) reported operating lease liabilities (total) of $143.22M in Q4 2025.
- How has AbCellera Biologics Inc.'s operating lease liabilities (total) changed year-over-year?
- AbCellera Biologics Inc.'s operating lease liabilities (total) increased by 119.1% year-over-year, from $65.36M to $143.22M.
- What is the long-term trend for AbCellera Biologics Inc.'s operating lease liabilities (total)?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s operating lease liabilities (total) has grown at a 100.8% compound annual growth rate (CAGR), from $4.39M to $143.22M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.
Ask your AI about AbCellera Biologics Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude